Promoter- and cell-specific responses to sex steroids

Osteoporosis International

Volumn 7, Issue SUPPL. 1, 1997, Pages 23-28

  Milgrom, E ^a   Savouret, J F ^a   Mantel, A ^a   Perrot Applanat, M ^a   Delabre, K ^a   Lescop, P ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CELL PROTEIN; ESTROGEN RECEPTOR; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE RECEPTOR; SEX HORMONE; STEROID RECEPTOR;

ACTIVE TRANSPORT; CELL ACTIVITY; CELL NUCLEUS; CONFERENCE PAPER; DNA SEQUENCE; DRUG MECHANISM; EXPRESSION VECTOR; GENETIC TRANSCRIPTION; HUMAN; MEMBRANE TRANSPORT; MENSTRUAL CYCLE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; TRANSACTIVATION;

EID: 0030997069     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01674809     Document Type: Conference Paper

References (40)

1. King WJ, Greene GL. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 1984;307:745-7.
2. Perrot-Applanat M, Logeat F, Groyer-Picard MT,Milgrom E. Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 1985;116:1473-84.
3. Welshons WV, Lieberman ME, Gorski J. Nuclear localization of unoccupied oestrogen receptors. Nature 1984; 307:747-9.
4. Guiochon-Mantel A, Loosfelt H, Lescop P, et al. Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell 1989; 57:1147-54.
5. Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M, Milgrom E. Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J 1991;10:3851-9.
6. Madan AP, DeFranco DB. Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci USA 1993;90:3588-92.
7. Dauvois S, White R, Parker MG. The antiestrogen ICI182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 1993;106:1377-88.
8. Perrot-Applanat M, Lescop P, Milgrom E. The cytoskeleton and the cellular traffic of the progesterone receptor. J Cell Biol 1992;119:337-38.
9. Mandell RB, Feldherr CM. Identification of two hsp70-related Xenopus oocyte proteins that are capable of recycling across the nuclear envelope. J Cell Biol 1990;111:1775-83.
10. Guiochon-Mantel A, Delabre K, Lescop P, Milgrom E. Nuclear localization signals also mediate the outward movement of proteins from the nucleus. Proc Natl Acad Sci USA 1994;91:7179-83.
11. Klein-Hitpass L, Cato ACB, Henderson D, Ryffel GU. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucleic Acids Res 1991;19:1227-34.
12. Delabre K, Guiochon-Mantel A, Milgrom E. In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA. Proc Natl Acad Sci USA 1993;90:4421-5.
13. Guiochon-Mantel A, Loosfelt H, Ragot T, etal. Receptors bound to antiprogestin form abortive complexes with hormone responsive elements. Nature 1988;336:695-8.
14. Milgrom E, Luu Thi MT, Atger M,Baulieu EE. Mechanisms regulating the concentration and the conformation of progesterone receptor(s) in the uterus. J Biol Chem 1973;248:6366-74.
15. Vu Hai MT, Logeat F, Warembourg M, Milgrom E. Hormonal control of progesterone receptors. Ann NY Acad Sci 1977;286:199-209.
16. Mester J, Baulieu EE. Progesterone receptors in the chicken oviduct. Eur J Biochem 1977;72:403-14.
17. Horwitz KB, McGuire WL. Oestrogen control of progesterone receptor in human breast cancer. J Biol Chem 1978;253:2223-8.
18. Garcia E, Bouchard P, De Brux J, et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 1988;67:80-7.
19. Chalbos D, Vignon F, Keydar I, Rochefort H. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab 1982;55:276-83.
20. Prud'homme JF, Fridlansky F, Le Cunff M, et al. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 1985;4:11-21.
21. Savouret JF, Bailly A, Misrahi M, et al. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J 1991;10:1875-83.
22. Berry M, Metzger D, Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 1990;9:2811-8.
23. Savouret JF, Rauch M, Redeuilh G, et al. Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene J Biol Chem 1994;269:28955-62.
24. Onate SA, Tsai SY, Tsai MJ, O'Malley BW Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995;270:1354-7.
25. Cavaillès V, Dauvois S, Danielian PS, Parker MG. Interaction of proteins with transcriptionally active estrogen receptor. Proc Natl Acad Sci USA 1994;91:10009-13.
26. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996;15:3667-75.
27. Halachmi S, Marden E, Martin G, Mackay H, Abbondanza C, Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 1994;264:1455-8.
28. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996;85:403-14.
29. Hörlein AJ, Näär AM, Heinzel T, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995;377:397-404.
30. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995;377:454-7.
31. Cavaillès V, Dauvois S, L'Horset F, et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 1995;14:3741-51.
32. Le Douarin B, Zechel C, Garnier JM, et al. The N-terminal, part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995;14:2020-33.
33. vom Baur E, Zechel C, Heery D, et al. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 1996;15:110-24.
34. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 1995;374:91-4.
35. Guiochon-Mantel A, Savouret JF, Quignon F, Delabre K, Milgrom E, de Thé H. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol Endocrinol 1995;9:1791-803.
36. Imhof MO, McDonnell DP. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transactivation by human progesterone and glucocorticoid receptors. Mol Cell Biol 1996;16:2594-605.
37. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor gene to a novel transcribed locus. Nature 1990;347:558-61.
38. Muchardt C, Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 1993;12:4279-90.
39. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2, and SWI3. Proteins for transcriptional enhancement by steroid receptors. Science 1992;258:1598-604.
40. Struhl K. Chromatin structure and RNA polymerase II connection: implications for transcription. Cell 1996;84:179-82.